Valuation: Cutia Therapeutics

Market Cap 836M 963M 123M 108M 99.46M 91.91M 174M 11.76B 178M 1.2B 465M 5.76B 461M 451M 19.98B P/E 2026 *
-5.02x
P/E 2027 * 17.6x
Enterprise Value 904M 1.04B 133M 117M 108M 99.47M 189M 12.73B 192M 1.29B 503M 6.23B 499M 488M 21.62B EV / Sales 2026 *
1.4x
EV / Sales 2027 * 0.71x
Free-Float
35.44%
Yield 2026 *
-
Yield 2027 * -
1 day+1.51%
1 week-6.60%
Current month-4.95%
1 month-17.74%
3 months-41.39%
6 months-48.27%
Current year-40.75%
1 week 2.57
Extreme 2.57
2.88
1 month 2.57
Extreme 2.57
3.57
Current year 2.57
Extreme 2.57
5.51
1 year 2.57
Extreme 2.57
12
3 years 2.57
Extreme 2.57
31
5 years 2.57
Extreme 2.57
32.6
10 years 2.57
Extreme 2.57
32.6
Manager TitleAgeSince
Chief Executive Officer 48 31/08/2019
Director of Finance/CFO 36 09/05/2021
Chief Tech/Sci/R&D Officer 42 09/01/2020
Director TitleAgeSince
Director/Board Member 48 11/05/2020
Chairman 63 22/08/2019
Director/Board Member 36 14/11/2022
Date Insider Type Main position Quantity % Market Cap.
14/10/24Other

Founder

15,000 0.0049%
02/10/24Other

Chief Financial Officer

20,000 0.0066%
01/10/24Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
+1.51%-6.60%-68.54%-87.49% 123M
+0.18%+0.13%+54.46%+168.23% 1,084B
-0.40%-0.39%+67.65%+64.26% 634B
+0.42%-2.81%+33.11%+88.67% 447B
+0.28%-1.79%+29.00%+26.45% 330B
-7.51%-10.17%+26.04%+28.29% 295B
-0.89%-2.25%+28.28%+45.88% 285B
-0.62%-3.07%-27.37%-39.39% 218B
-0.82%-2.70%+22.77%+61.99% 199B
-0.88%+2.21%+18.48%+77.26% 169B
Average -0.85%+1.63%+18.39%+43.42% 366B
Weighted average by Cap. -0.68%+2.48%+39.26%+84.59%

Financials

2026 *2027 *
Net sales 646M 744M 94.93M 83.27M 76.87M 71.04M 135M 9.09B 137M 924M 359M 4.45B 357M 349M 15.44B 1.18B 1.36B 173M 152M 140M 130M 246M 16.6B 251M 1.69B 656M 8.13B 651M 637M 28.21B
Net income -146M -168M -21.42M -18.79M -17.35M -16.03M -30.38M -2.05B -30.99M -209M -81.02M -1B -80.44M -78.68M -3.48B 44.25M 50.99M 6.5M 5.7M 5.27M 4.87M 9.22M 623M 9.41M 63.31M 24.6M 305M 24.42M 23.89M 1.06B
Net Debt 68.7M 79.16M 10.1M 8.86M 8.18M 7.56M 14.32M 967M 14.61M 98.3M 38.19M 473M 37.92M 37.09M 1.64B -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
304
Date Price Change Volume
09/07/26 HK$2.690 +1.51% 37,800
08/07/26 HK$2.650 0.00% 9,600
07/07/26 HK$2.650 -5.69% 180,600
06/07/26 HK$2.810 +2.55% 8,800
03/07/26 HK$2.740 -4.86% 237,000
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.300CNY
Average target price
9.801CNY
Spread / Average Target
+326.19%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock